Front Page › Investigations › Who Owns Connecticut Cannabis, and Who Pays
Who Owns Connecticut Cannabis, and Who Pays
The families, companies and lenders behind Connecticut's cannabis licenses, the campaign money and lobbying around the industry, the financial disclosures of the officials who regulate it, and the federal probe touching all of it.
License rolls say who holds a cannabis license. They do not say who put up the money, who sits on the boards, or which lawmakers took the contributions. This investigation assembles that picture from state license records, Statements of Financial Interests, campaign finance filings, court dockets and the public record of a federal grand jury probe. It includes one corrected story, logged on the corrections page.
Main story
Corrected: Who Really Controls Connecticut Cannabis
Connecticut’s cannabis market was supposed to open the door for hundreds of small, locally owned businesses.
Recent developments
- Seeking Interviews: Social Equity Owners, JV Partners, Operators and Cultivation EmployeesOctober 8, 2026 · The Editor's Desk
- Where Is the Line?September 16, 2026 · Money & Influence
- The Pequot Compact Shows the Licensing Barriers Were Always ManufacturedJune 26, 2026 · Regulators
Timeline
- October 8, 2026StorySeeking Interviews: Social Equity Owners, JV Partners, Operators and Cultivation Employees
- September 16, 2026StoryWhere Is the Line?
- June 26, 2026StoryThe Pequot Compact Shows the Licensing Barriers Were Always Manufactured
- June 10, 2026StoryEquity Grants Need Public Trust. So Why Is Doug McCrory Hosting the Forum?
- May 14, 2026StoryTyson 2.0 Launch Exposes the 'White Label' Market and Social Equity Contradictions
- April 26, 2026StoryFBI-Linked Blue Hills Investigation Raises Questions Near the Social Equity System
- April 22, 2026StoryHB 5350 Opens Door to Sale of Social Equity Cannabis Businesses After Six Years
- April 4, 2026StoryHouse Majority Leader Jason Rojas’ PAC Took Cannabis-Linked Money Tied to Crisp Network
- March 11, 2026StoryCorporate Cannabis Blames the 'Illicit Market.' Connecticut Built It.
- December 4, 2025StoryConnecticut Taxpayers Fund a National Regulator Network. DCP's Commissioner Sits on Its Board
- November 21, 2025StoryThe Cicero Connection: Cannabis, Power and the Expanding Federal Probe
- November 7, 2025StoryCorrected: Who Really Controls Connecticut Cannabis
- November 7, 2025Corrected version published after the two Patel networks were conflated.
- November 5, 2025The Hidden Empire: license analysis of the Zachs and Patel networks published.
- November 3, 2025StoryState Records Confirm Silver Point Subsidiary Now Holds Theraplant's License
- November 3, 2025StoryTrustee Alleges Greenrose Board and Lender Conspired to Seize Theraplant in Secret Foreclosure
- October 16, 2025StoryARPA Funds Meant for a Downtown Market Appear Diverted Toward Dispensary Linked to Former Regulator
- August 5, 2025StoryFederal Probe Ties Cannabis Consulting, Nonprofit Grants and Political Power
- August 1, 2025StoryFederal Grand Jury Probe Deepens as State Confirms Cooperation
- August 1, 2025StoryFederal Grand Jury Probe Reaches From the Capitol to the Dispensary
All stories in this investigation (18)
Seeking Interviews: Social Equity Owners, JV Partners, Operators and Cultivation Employees
Connecticut CannaTimes is hoping to connect with Derrick Gibbs of Budr Cannabis, Jocelyn Cerda of Shangri-La CT, and other social equity owners, equity joint venture partners, cannabis business operators, and individuals with firsthand experience navigating Connecticut’s licensed cannabis market.
Where Is the Line?
Connecticut’s cannabis industry openly honors the lawmakers and regulators who shape its market. Maybe the problem isn’t what’s hidden. Maybe it’s what we’ve decided is normal.
The Pequot Compact Shows the Licensing Barriers Were Always Manufactured
For years, the state treated cannabis licenses like golden tickets. Limited licenses. Lottery windows. Application fees. Social Equity Council reviews. DCP bottlenecks. Ownership audits. Residency tests. Income tests. Backer scrutiny. Management agreement restrictions. Years of delay.
Equity Grants Need Public Trust. So Why Is Doug McCrory Hosting the Forum?
As Connecticut prepares to distribute millions of dollars in cannabis tax revenue through the Social Equity Council’s Reimagine & Revitalize (R2) Community Reinvestment Program, an uncomfortable question is emerging:
Tyson 2.0 Launch Exposes the 'White Label' Market and Social Equity Contradictions
Connecticut consumers are being told that Mike Tyson’s cannabis brand is officially coming to the state through Rodeo Cannabis in Rocky Hill.
FBI-Linked Blue Hills Investigation Raises Questions Near the Social Equity System
A federal investigation into the collapse of a Hartford nonprofit is raising new oversight questions that now sit uncomfortably close to Connecticut’s cannabis social equity system.
HB 5350 Opens Door to Sale of Social Equity Cannabis Businesses After Six Years
Hartford, CT — A provision in the amended version of House Bill 5350 creates a clear pathway for Social Equity cannabis businesses in Connecticut to be sold or transferred after a set period; while requiring a fixed state fee each time ownership changes.
House Majority Leader Jason Rojas’ PAC Took Cannabis-Linked Money Tied to Crisp Network
Three dispensary entities connected to the same business structure made coordinated payments into leadership PAC.
Corporate Cannabis Blames the 'Illicit Market.' Connecticut Built It.
First and foremost, never forget that CT Cannabis Corporations are lobbying against your personal freedom and rights, and actively advocating for enforcement against the legacy market, all while blaming the little guys, the basement growers, for their corporations failures.
Connecticut Taxpayers Fund a National Regulator Network. DCP's Commissioner Sits on Its Board
How Connecticut quietly pays into a secretive national association that helps write cannabis policy behind closed doors — while one of our own regulators helps lead it.
The Cicero Connection: Cannabis, Power and the Expanding Federal Probe
A NEW NAME EMERGES IN CONNECTICUT’S CANNABIS EQUITY LANDSCAPE — AND IN A FEDERAL PROBE
State Records Confirm Silver Point Subsidiary Now Holds Theraplant's License
Public records now confirm that DXR Finance 3, LLC, a corporate affiliate of Silver Point Capital, currently holds Connecticut Medical Marijuana Producer License MMPR.0000004 at 856 Echo Lake Road in Watertown — the same facility historically operated by Theraplant LLC.
Trustee Alleges Greenrose Board and Lender Conspired to Seize Theraplant in Secret Foreclosure
November 3rd, 2025 — Hartford, CT - Via Anonymous CT CannaTimes Contributors
ARPA Funds Meant for a Downtown Market Appear Diverted Toward Dispensary Linked to Former Regulator
A formal fraud-risk review request has been submitted to the Connecticut Auditors of Public Accounts, calling for an investigation into the City of Middletown’s use of $2.5 million in ARPA funds earmarked for Main Street redevelopment.
Federal Probe Ties Cannabis Consulting, Nonprofit Grants and Political Power
A sweeping federal grand jury investigation into state-funded nonprofits and political favoritism in Connecticut is exposing deeper links to cannabis licensing, questionable grants, and influence-peddling—centered around Senator Douglas McCrory (D-Bloomfield) and his longtime associate, Sonserae “Cicero” Hamlin, operator of the startup nonprofit SHEBA (Society for Human Engagem
Federal Grand Jury Probe Deepens as State Confirms Cooperation
HARTFORD, CT — A new Hartford Courant report confirms that the State of Connecticut is officially cooperating with a federal grand jury investigating the misuse of tens of millions in nonprofit grant funding — and cannabis licensing corruption is now on the radar.
Federal Grand Jury Probe Reaches From the Capitol to the Dispensary
A sweeping federal investigation has cracked open what cannabis advocacy groups have warned for years: Connecticut’s cannabis licensing system, social equity rollout, and COVID-relief grant distribution may be riddled with fraud, insider deals, and political favoritism.